We have found 29 companies that use SnpEff. The companies using SnpEff are most often found in United States and in the Hospital & Health Care industry. SnpEff is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for SnpEff usage goes back as far as 11 months.
|GNS Healthcare, Inc.||gnshealthcare.com||United States||10M-50M||50-200|
|UNIVERSITY OF PITTSBURGH||pitt.edu||United States||10M-50M||>10000|
|The Children's Hospital of Philadelphia||chop.edu||United States||>1000M||>10000|
|Guardant Health Inc||guardanthealth.com||United States||50M-100M||200-500|
|Cancer Genetics Inc||cancergenetics.com||United States||10M-50M||200-500|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, SnpEff has a market share of about 0.1%. Other major and competing products in this category include:
SnpEff is an open source tool that annotates variants and predicts their effects on genes by using an interval forest approach. This program takes pre-determined variants listed in a data file that contains the nucleotide change and its position and predicts if the variants are deleterious.
Looking at SnpEff customers by industry, we find that Hospital & Health Care (29%) and Higher Education (29%) are the largest segments.
|Industry||Number of companies|
|Hospital & Health Care||9|
|Defense & Space||1|
78% of SnpEff customers are in United States and 5% are in United Kingdom.
|Country||Number of companies|
|Employees||Number of companies|
|Revenue (in USD)||Number of companies|